Camelot Portfolios’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-461
| Closed | -$48.6K | – | 404 |
|
|
2025
Q4 | $48.6K | Buy |
+461
| New | +$43.3K | 0.03% | 317 |
|
|
2024
Q3 | – | Sell |
-553
| Closed | -$68.4K | – | 396 |
|
|
2024
Q2 | $68.4K | Buy |
+553
| New | +$71.2K | 0.04% | 279 |
|
|
2024
Q1 | – | Sell |
-1,884
| Closed | -$205K | – | 180 |
|
|
2023
Q4 | $205K | Buy |
+1,884
| New | +$196K | 0.12% | 188 |
|
|
2023
Q3 | – | Sell |
-2,941
| Closed | -$339K | – | 171 |
|
|
2023
Q2 | $339K | Sell |
2,941
-1,752
| -37% | -$199K | 0.21% | 126 |
|
|
2023
Q1 | $499K | Buy |
4,693
+61
| +1% | +$6.59K | 0.35% | 87 |
|
|
2022
Q4 | $514K | Buy |
4,632
+1,086
| +31% | +$111K | 0.38% | 80 |
|
|
2022
Q3 | $305K | Sell |
3,546
-3,160
| -47% | -$282K | 0.29% | 101 |
|
|
2022
Q2 | $611K | Sell |
6,706
-1,301
| -16% | -$115K | 0.37% | 89 |
|
|
2022
Q1 | $657K | Sell |
8,007
-3,837
| -32% | -$303K | 0.33% | 95 |
|
|
2021
Q4 | $908K | Buy |
11,844
+4,250
| +56% | +$339K | 0.37% | 87 |
|
|
2021
Q3 | $570K | Sell |
7,594
-3,514
| -32% | -$267K | 0.29% | 102 |
|
|
2021
Q2 | $864K | Sell |
11,108
-1,088
| -9% | -$80.9K | 0.35% | 90 |
|
|
2021
Q1 | $897K | Buy |
12,196
+5,818
| +91% | +$429K | 0.37% | 84 |
|
|
2020
Q4 | $498K | Buy |
+6,378
| New | +$488K | 0.26% | 105 |
|
|
2017
Q4 | – | Sell |
-4,278
| Closed | -$261K | – | 194 |
|
|
2017
Q3 | $261K | Buy |
4,278
+1
| +0% | +$61 | 0.13% | 141 |
|
|
2017
Q2 | $262K | Sell |
4,277
-3,867
| -47% | -$235K | 0.13% | 142 |
|
|
2017
Q1 | $494K | Buy |
8,144
+35
| +0.4% | +$2.12K | 0.24% | 102 |
|
|
2016
Q4 | $456K | Hold |
8,109
| – | – | 0.24% | 103 |
|
|
2016
Q3 | $483K | Buy |
8,109
+1,677
| +26% | +$98.1K | 0.26% | 99 |
|
|
2016
Q2 | $354K | Hold |
6,432
| – | – | 0.21% | 104 |
|
|
2016
Q1 | $325K | Sell |
6,432
-2,986
| -32% | -$146K | 0.2% | 108 |
|
|
2015
Q4 | $475K | Buy |
+9,418
| New | +$475K | 0.3% | 84 |
|
|
2015
Q3 | – | Sell |
-3,772
| Closed | -$205K | – | 165 |
|
|
2015
Q2 | $205K | Buy |
+3,772
| New | +$212K | 0.12% | 154 |
|
|
2015
Q1 | – | Sell |
-3,812
| Closed | -$207K | – | 176 |
|
|
2014
Q4 | $207K | Sell |
3,812
-78
| -2% | -$4.35K | 0.12% | 150 |
|
|
2014
Q3 | $220K | Hold |
3,890
| – | – | 0.13% | 145 |
|
|
2014
Q2 | $215K | Buy |
+3,890
| New | +$212K | 0.14% | 146 |
|
Other funds holding MRK
Camelot Portfolios's MRK Position: Q1 2026 in Review
Camelot Portfolios sold out of Merck (MRK) in Q1 2026, closing a stake of 461 shares — an estimated $48.6K sold.
Camelot Portfolios first reported a position in MRK in Q2 2014 and held it in 26 quarters. The position peaked at $908K in Q4 2021. 3,796 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Camelot Portfolios reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
- Camelot Portfolios sold 461 Merck shares in Q1 2026, an estimated $48.6K.
- Camelot Portfolios first reported a position in Merck in Q2 2014 and held it in 26 quarters.
- Camelot Portfolios's Merck position peaked at $908K in Q4 2021.
- 3,796 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.